RE: Nasdaq18 Aug 2021 19:11
Also rumour on Advfn BB citing genetics research can indicate disposition to CKD.
If this has led to fall in value in Renx, the ignorance must be incredible.
a/ If you have a certain genes, we already know that you have a pre disposition to diabetes.
b/ If you have a certain genes, we already know that too that you have a higher probability of Alzheimers.
c/ Same applies for Cardiovascular disease.
Under a/ it does not render the blood sugar monitor useless does it? Or the Hb1AC test
Under b/ ok - unexplored yet. Nothing concrete as a predictive tool for onset of AD.
Under c/ Just coz you got some genes that increases your chances, u still need to do your Calcium scoring + other predictive assessments that determine your likelihood of getting heart disease.
So bottom line, Renx remains fully valid.